Farmacología y Microbiología Molecular

Sundaram V; Petkova MI; Pujol-Carrion N; Boada J; de la Torre-Ruiz MA

Tor1, Sch9 and PKA downregulation in quiescence rely on Mtl1 to preserve mitochondrial integrity and cell survival

MOLECULAR MICROBIOLOGY 97 93-109. 01/07/2015.

[doi:10.1111/mmi.13013]

G Cortés JC; Pujol N; Sato M; Pinar M; Ramos M; Moreno B; Osumi M; Ribas JC; Pérez P

Cooperation between Paxillin-like Protein Pxl1 and Glucan Synthase Bgs1 Is Essential for Actomyosin Ring Stability and Septum Formation in Fission Yeast

Plos Genetics 11 -. 01/07/2015.

[doi:10.1371/journal.pgen.1005358]

Muniesa Royo M; March de Ribot A; Sánchez-de-la-Torre M; Huerva Escanilla V; Jurjo Campo C; Barbé Illa F

Corneal Biomechanical Properties in Floppy Eyelid Syndrome

Cornea 34 521-524. 01/05/2015.

[doi:10.1097/ICO.0000000000000396]

Huerva V; Carmen Sanchez M; Jesus Muniesa M

ExPRESS Shunt Surgery for Glaucoma with Post-Traumatic Aniridia

Seminars in Ophthalmology 30 218-220. 01/05/2015.

[doi:10.3109/08820538.2013.835845]

Huerva V; Sanchez MC

Infectious Crystalline Keratopathy Caused by Pseudomonas fluorescens

EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE 41 9-10. 01/03/2015.

[doi:10.1097/ICL.0b013e3182a2f91d]

Borrás Pérez, V.; López-Siguero, J.P.; Martínez, G.; Corripio, R.; Fernández, J.M.; Labarta, J.I.; Ferrer, M.; Cabrinety, N.; Prieto, P.; Ramón-Krauel, M.; Bosch, J.; Espino, R.; Palla Garcia, M.; Rebollo, F.J.

A Follow-up Study to Monitor Adult Height Among Spanish Children with Growth Hormone Deficiency Who Received Biosimilar Human Recombinant Growth Hormone (Omnitrope(A (R))) During a Phase III Clinical Trial

Advances in Therapy 32 148-156. 01/02/2015.

[doi:10.1007/s12325-015-0181-9]

Huerva V; Ascaso FJ; Grzybowski A

Ocular Inflammation

Mediators of Inflammation 2015 398076-398076. 13/01/2015.

[doi:10.1155/2015/398076]

Huerva V

Lichen planus on the ocular surface

Cutaneous And Ocular Toxicology 34 232-233. 01/01/2015.

[doi:10.3109/15569527.2014.944651]

Ribas J; Mattiolo P; Boix J

Pharmacological Modulation of Reactive Oxygen Species in Cancer Treatment

CURRENT DRUG TARGETS 16 31-37. 01/01/2015.

[doi:10.2174/1389450115666141114153536]

de la Torre-Ruiz MA; Pujol N; Sundaram V

Coping With Oxidative Stress. The Yeast Model

CURRENT DRUG TARGETS 16 2-12. 01/01/2015.

[doi:10.2174/1389450115666141020160105]

De La Torre Ruiz MA

Unraveling oxidative stress. From yeast to human therapy.

CURRENT DRUG TARGETS 16 1-1. 01/01/2015.

Milara J; Outeda-Macias M; Aumente-Rubio MD; Más-Serrano P; Aldaz A; Calvo MV; García-Simón MS; Martin-Barbero M; Padullés-Zamora N; Schoenenberger JA; Saavedra-Aldrich M; Tévar-Alfonso E; Saval A; Pastor-Clerigues A; García M; Margusino-Framiñan L; Montero-Alvarez JL; Merino E; Herrero JI; Beunza M; Conesa-Zamora P; Gimenez-Manzorro A; Comas-Sugrañes D; Cano-Marron M; Jiménez-Mutiloa E; Díaz-Ruíz P; Cortijo J

PEG-Interferon-a ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 39 29-43. 01/01/2015.

[doi:10.7399/fh.2015.39.1.8547]